Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oliver FitzGerald

Showing results (1-10 of 288) with videos related to

Pageof 29
Sort By:
Arthritis Research & Therapy|May 19, 2005
Psoriatic arthritis synovial histopathology: commentary on the article by Kruithof and colleaguesOliver Fitzgerald
Nature Reviews. Rheumatology|May 25, 2016
Spondyloarthropathies: IL-6 blockade in psoriatic arthritis - a new therapeutic option?Oliver FitzGerald
Nature Reviews. Rheumatology|May 22, 2014
Spondyloarthropathies: Apremilast: welcome advance in treatment of psoriatic arthritisOliver FitzGerald
Nature Reviews. Rheumatology|October 17, 2012
Diagnosis: Screening for arthritis in patients with psoriasisOliver FitzGerald
Current Rheumatology Reports|May 5, 2010
Application of the GRAPPA psoriatic arthritis treatment recommendations in clinical practiceAizad Mumtaz, Oliver FitzGerald
Expert Review of Clinical Immunology|January 7, 2016
Psoriatic arthritis: complexities, comorbidities and implications for the clinicMuhammad Haroon, Oliver FitzGerald
The Journal of Rheumatology. Supplement|July 4, 2012
Pathogenetic overview of psoriatic diseaseMuhammad Haroon, Oliver Fitzgerald
Current Opinion in Rheumatology|May 16, 2020
MHC class I associations beyond HLA-B27: the peptide binding hypothesis of psoriatic arthritis and its implications for disease pathogenesisRobert Winchester, Oliver FitzGerald
Best Practice & Research. Clinical Rheumatology|June 17, 2006
Psoriatic arthritis: one or more diseases?Oliver Fitzgerald, Maxime Dougados
Arthritis & Rheumatology (Hoboken, N.J.)|January 29, 2014
Editorial: emerging evidence for critical involvement of the interleukin-17 pathway in both psoriasis and psoriatic arthritisOliver Fitzgerald, Robert Winchester
Pageof 29

Showing results (1-10 of 288) with videos related to

Sort By:
Pageof 29
Arthritis Research & Therapy|May 19, 2005
Psoriatic arthritis synovial histopathology: commentary on the article by Kruithof and colleaguesOliver Fitzgerald
Nature Reviews. Rheumatology|May 25, 2016
Spondyloarthropathies: IL-6 blockade in psoriatic arthritis - a new therapeutic option?Oliver FitzGerald
Nature Reviews. Rheumatology|May 22, 2014
Spondyloarthropathies: Apremilast: welcome advance in treatment of psoriatic arthritisOliver FitzGerald
Nature Reviews. Rheumatology|October 17, 2012
Diagnosis: Screening for arthritis in patients with psoriasisOliver FitzGerald
Current Rheumatology Reports|May 5, 2010
Application of the GRAPPA psoriatic arthritis treatment recommendations in clinical practiceAizad Mumtaz, Oliver FitzGerald
Expert Review of Clinical Immunology|January 7, 2016
Psoriatic arthritis: complexities, comorbidities and implications for the clinicMuhammad Haroon, Oliver FitzGerald
The Journal of Rheumatology. Supplement|July 4, 2012
Pathogenetic overview of psoriatic diseaseMuhammad Haroon, Oliver Fitzgerald
Current Opinion in Rheumatology|May 16, 2020
MHC class I associations beyond HLA-B27: the peptide binding hypothesis of psoriatic arthritis and its implications for disease pathogenesisRobert Winchester, Oliver FitzGerald
Best Practice & Research. Clinical Rheumatology|June 17, 2006
Psoriatic arthritis: one or more diseases?Oliver Fitzgerald, Maxime Dougados
Arthritis & Rheumatology (Hoboken, N.J.)|January 29, 2014
Editorial: emerging evidence for critical involvement of the interleukin-17 pathway in both psoriasis and psoriatic arthritisOliver Fitzgerald, Robert Winchester
Pageof 29